Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives
- PMID: 34068884
- PMCID: PMC8156434
- DOI: 10.3390/jcm10102118
Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives
Abstract
Episcleritis and scleritis are the most common ocular inflammatory manifestation of rheumatoid arthritis. Rheumatoid arthritis (RA) accounts for 8% to 15% of the cases of scleritis, and 2% of patients with RA will develop scleritis. These patients are more likely to present with diffuse or necrotizing forms of scleritis and have an increased risk of ocular complications and refractory scleral inflammation. In this review we provide an overview of diagnosis and management of rheumatoid arthritis-associated episcleritis and scleritis with a focus on recent treatment perspectives. Episcleritis is usually benign and treated with oral non-steroidal anti- inflammatory drugs (NSAIDs) and/or topical steroids. Treatment of scleritis will classically include oral NSAIDs and steroids but may require disease-modifying anti-rheumatic drugs (DMARDs). In refractory cases, treatment with anti TNF biologic agents (infliximab, and adalimumab) is now recommended. Evidence suggests that rituximab may be an effective option, and further studies are needed to investigate the potential role of gevokizumab, tocilizumab, abatacept, tofacitinib, or ACTH gel. A close cooperation is needed between the rheumatology or internal medicine specialist and the ophthalmologist, especially when scleritis may be the first indicator of an underlying rheumatoid vasculitis.
Keywords: biologics; episcleritis; ocular inflammation; prognosis; rheumatoid arthritis; scleritis; treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
[Scleritis and episcleritis].Rev Med Interne. 2023 Dec;44(12):646-655. doi: 10.1016/j.revmed.2023.05.013. Epub 2023 Jun 19. Rev Med Interne. 2023. PMID: 37344292 Review. French.
-
Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis).Jpn J Ophthalmol. 2019 Sep;63(5):417-424. doi: 10.1007/s10384-019-00674-7. Epub 2019 Jun 10. Jpn J Ophthalmol. 2019. PMID: 31183624
-
[Diagnostic and Therapeutic Management of Episcleritis and Scleritis].Klin Monbl Augenheilkd. 2023 May;240(5):725-738. doi: 10.1055/a-2022-0689. Epub 2023 Feb 24. Klin Monbl Augenheilkd. 2023. PMID: 36827997 German.
-
Ocular inflammatory diseases associated with rheumatoid arthritis.Nat Rev Rheumatol. 2014 Feb;10(2):108-16. doi: 10.1038/nrrheum.2013.185. Epub 2013 Dec 10. Nat Rev Rheumatol. 2014. PMID: 24323074 Review.
-
Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.J Rheumatol. 2018 May;45(5):595-603. doi: 10.3899/jrheum.170437. Epub 2018 Feb 15. J Rheumatol. 2018. PMID: 29449499
Cited by
-
Posterior Scleritis: A Case Report and Literature Review of the Management of the Condition.Cureus. 2024 Jun 2;16(6):e61537. doi: 10.7759/cureus.61537. eCollection 2024 Jun. Cureus. 2024. PMID: 38831917 Free PMC article.
-
A rare case of scleritis and multiple rheumatoid pulmonary nodules associated with seronegative rheumatoid arthritis.Oxf Med Case Reports. 2023 Jan 18;2023(1):omac155. doi: 10.1093/omcr/omac155. eCollection 2023 Jan. Oxf Med Case Reports. 2023. PMID: 36694604 Free PMC article.
-
Mitochondrial and microtubule defects in Exfoliation Glaucoma.Free Radic Biol Med. 2025 Jun;233:226-239. doi: 10.1016/j.freeradbiomed.2025.03.046. Epub 2025 Apr 1. Free Radic Biol Med. 2025. PMID: 40180018
-
Spectrum of and Factors Associated with Eye Disorders among Rheumatoid Arthritis Patients Attending Tertiary Hospital in Uganda.Open Access Rheumatol. 2023 Jul 13;15:103-111. doi: 10.2147/OARRR.S413697. eCollection 2023. Open Access Rheumatol. 2023. PMID: 37465162 Free PMC article.
-
Connective tissue disorders and eye: A review and recent updates.Indian J Ophthalmol. 2023 Jun;71(6):2385-2398. doi: 10.4103/ijo.IJO_286_22. Indian J Ophthalmol. 2023. PMID: 37322648 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources